Clinical Trial Update: A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion [Phase 4]

View source ↗

Summary

Phase 4 pilot study comparing nateglinide with glibenclamide to assess renal hemodynamics and albumin excretion in type 2 diabetes. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glibenclamide (glibenclamide)
• Nateglinide (nateglinide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED